{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:17:38Z","timestamp":1789690658262,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"DOI":"10.1038\/s41387-024-00323-0","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T05:03:05Z","timestamp":1722920585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pathogenic gene connections in type 2 diabetes and non-alcoholic fatty liver disease: a bioinformatics analysis and mouse model investigations experiments"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3191-0838","authenticated-orcid":false,"given":"Chao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4199-1685","authenticated-orcid":false,"given":"Kunhuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3198-7487","authenticated-orcid":false,"given":"Yuhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8603-8776","authenticated-orcid":false,"given":"Meiqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8455-3478","authenticated-orcid":false,"given":"Zheng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,6]]},"reference":[{"key":"323_CR1","doi-asserted-by":"crossref","unstructured":"Elliott P. Joslin. The Prevention of Diabetes Mellitus. JAMA 2021;325:190.","DOI":"10.1001\/jama.2020.17738"},{"key":"323_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1570161117666190405165911","volume":"18","author":"D Lovic","year":"2020","unstructured":"Lovic D, Piperidou A, Zografou I, Grassos H, Pittaras A, Manolis A. The Growing Epidemic of Diabetes Mellitus. Curr Vasc Pharmacol. 2020;18:104\u20139.","journal-title":"Curr Vasc Pharmacol"},{"key":"323_CR3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","volume":"16","author":"JB Cole","year":"2020","unstructured":"Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16:377\u201390.","journal-title":"Nat Rev Nephrol"},{"key":"323_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","volume":"73","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhang Y, Graham S, Wang X, Cai D, Huang M, et al. Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping. J Hepatol. 2020;73:263\u201376.","journal-title":"J Hepatol"},{"key":"323_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"323_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","volume":"17","author":"D Ferguson","year":"2021","unstructured":"Ferguson D, Finck BN. Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus. Nat Rev Endocrinol. 2021;17:484\u201395.","journal-title":"Nat Rev Endocrinol"},{"key":"323_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","volume":"71","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. J Hepatol. 2019;71:793\u2013801.","journal-title":"J Hepatol"},{"key":"323_CR8","doi-asserted-by":"publisher","first-page":"9674","DOI":"10.3748\/wjg.v22.i44.9674","volume":"22","author":"A Lonardo","year":"2016","unstructured":"Lonardo A, Ballestri S, Guaraldi G, Nascimbeni F, Romagnoli D, Zona S, et al. Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World J Gastroenterol. 2016;22:9674\u201393.","journal-title":"World J Gastroenterol"},{"key":"323_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.arcmed.2009.07.009","volume":"40","author":"H Lu","year":"2009","unstructured":"Lu H, Zeng L, Liang B, Shu X, Xie D. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. Arch Med Res. 2009;40:571\u20135.","journal-title":"Arch Med Res"},{"key":"323_CR10","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62:S47\u2013S64.","journal-title":"J Hepatol"},{"key":"323_CR11","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW-S, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212\u201324.","journal-title":"Lancet"},{"key":"323_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113888","volume":"176","author":"V Kumar","year":"2021","unstructured":"Kumar V, Xin X, Ma J, Tan C, Osna N, Mahato RI. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. Adv Drug Deliv Rev. 2021;176:113888.","journal-title":"Adv Drug Deliv Rev"},{"key":"323_CR13","doi-asserted-by":"publisher","first-page":"S174","DOI":"10.1089\/dia.2020.2513","volume":"22","author":"K Garg","year":"2020","unstructured":"Garg K, Brackett S, Hirsch IB, Garg SK. NAFLD\/NASH and Diabetes. Diabetes Technol Ther. 2020;22:S174\u201386.","journal-title":"Diabetes Technol Ther"},{"key":"323_CR14","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 2013;41:D991\u20135.","journal-title":"Nucleic Acids Res"},{"key":"323_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis","year":"2003","unstructured":"Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4:P3.","journal-title":"Genome Biol"},{"key":"323_CR16","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49:D605\u201312.","journal-title":"Nucleic Acids Res"},{"key":"323_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8:S11.","journal-title":"BMC Syst Biol"},{"key":"323_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y. HY: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc Ser B. 1995;57:289\u2013300.","journal-title":"J Royal Stat Soc Ser B"},{"key":"323_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154868","volume":"123","author":"TME Davis","year":"2021","unstructured":"Davis TME. Diabetes and metabolic dysfunction-associated fatty liver disease. Metabolism. 2021;123:154868.","journal-title":"Metabolism"},{"key":"323_CR20","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18:599\u2013612.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"323_CR21","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"323_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9999612","volume":"2021","author":"W Sha","year":"2021","unstructured":"Sha W, Hu F, Xi Y, Chu Y, Bu S. Mechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus. J Diabetes Res. 2021;2021:9999612.","journal-title":"J Diabetes Res"},{"key":"323_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115835","volume":"168","author":"Y Sun","year":"2023","unstructured":"Sun Y, Bai Y-P, Wang D-G, Xing Y-J, Zhang T, Wang W, et al. Protective effects of metformin on pancreatic \u03b2-cell ferroptosis in type 2 diabetes in vivo. Biomed Pharmacother. 2023;168:115835.","journal-title":"Biomed Pharmacother"},{"key":"323_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.biopsych.2017.06.004","volume":"83","author":"HB Nygaard","year":"2018","unstructured":"Nygaard HB. Targeting Fyn Kinase in Alzheimer\u2019s Disease. Biol Psychiatry. 2018;83:369\u201376.","journal-title":"Biol Psychiatry"},{"key":"323_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13046-023-02652-x","volume":"42","author":"S Peng","year":"2023","unstructured":"Peng S, Yin Y, Zhang Y, Zhu F, Yang G, Fu Y. FYN\/TOPK\/HSPB1 axis facilitates the proliferation and metastasis of gastric cancer. J Exp Clin Cancer Res. 2023;42:80.","journal-title":"J Exp Clin Cancer Res"},{"key":"323_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-03930-0","volume":"21","author":"S Peng","year":"2023","unstructured":"Peng S, Fu Y. FYN: emerging biological roles and potential therapeutic targets in cancer. J Transl Med. 2023;21:84.","journal-title":"J Transl Med"},{"key":"323_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5671803","volume":"2016","author":"Z Lv","year":"2016","unstructured":"Lv Z, Hu M, Ren X, Fan M, Zhen J, Chen L, et al. Fyn Mediates High Glucose-Induced Actin Cytoskeleton Reorganization of Podocytes via Promoting ROCK Activation In Vitro. J Diabetes Res. 2016;2016:5671803.","journal-title":"J Diabetes Res"},{"key":"323_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1152\/jn.00229.2016","volume":"116","author":"M Suo","year":"2016","unstructured":"Suo M, Wang P, Zhang M. Role of Fyn-mediated NMDA receptor function in prediabetic neuropathy in mice. J Neurophysiol. 2016;116:448\u201355.","journal-title":"J Neurophysiol"},{"key":"323_CR29","doi-asserted-by":"crossref","unstructured":"Rahman K, Desai C, Iyer SS, Thorn NE, Kumar P, Liu Y et al: Loss of Junctional Adhesion Molecule A Promotes Severe Steatohepatitis in Mice on a Diet High in Saturated Fat, Fructose, and Cholesterol. Gastroenterology 2016;151:733\u2013746.","DOI":"10.1053\/j.gastro.2016.06.022"},{"key":"323_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01517-9","volume":"21","author":"Z-D Shi","year":"2022","unstructured":"Shi Z-D, Hao L, Han X-X, Wu Z-X, Pang K, Dong Y, et al. Targeting HNRNPU to overcome cisplatin resistance in bladder cancer. Mol Cancer. 2022;21:37.","journal-title":"Mol Cancer"},{"key":"323_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31752-z","volume":"13","author":"T Sapir","year":"2022","unstructured":"Sapir T, Kshirsagar A, Gorelik A, Olender T, Porat Z, Scheffer IE, et al. Heterogeneous nuclear ribonucleoprotein U (HNRNPU) safeguards the developing mouse cortex. Nat Commun. 2022;13:4209.","journal-title":"Nat Commun"},{"key":"323_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05376-6","volume":"13","author":"B-Y Han","year":"2022","unstructured":"Han B-Y, Liu Z, Hu X, Ling H. HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms. Cell Death Dis. 2022;13:940.","journal-title":"Cell Death Dis"},{"key":"323_CR33","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s41431-023-01422-9","volume":"31","author":"S Lee","year":"2023","unstructured":"Lee S, Ochoa E, Badura-Stronka M, Donnelly D, Lederer D, Lynch SA, et al. Germline pathogenic variants in HNRNPU are associated with alterations in blood methylome. Eur J Hum Genet. 2023;31:1040\u20137.","journal-title":"Eur J Hum Genet"},{"key":"323_CR34","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.2337\/db21-1145","volume":"71","author":"X Shen","year":"2022","unstructured":"Shen X, Zhang Y, Ji X, Li B, Wang Y, Huang Y, et al. Long Noncoding RNA lncRHL Regulates Hepatic VLDL Secretion by Modulating hnRNPU\/BMAL1\/MTTP Axis. Diabetes. 2022;71:1915\u201328.","journal-title":"Diabetes"},{"key":"323_CR35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.18388\/abp.2007_3255","volume":"54","author":"P Bragoszewski","year":"2007","unstructured":"Bragoszewski P, Habior A, Walewska-Zielecka B, Ostrowski J. Expression of genes encoding mitochondrial proteins can distinguish nonalcoholic steatosis from steatohepatitis. Acta Biochim Pol. 2007;54:341\u20138.","journal-title":"Acta Biochim Pol"},{"key":"323_CR36","doi-asserted-by":"crossref","unstructured":"Ebersberger S, Hipp C, Mulorz MM, Buchbender A, Hubrich D, Kang H-S et al: FUBP1 is a general splicing factor facilitating 3\u2019 splice site recognition and splicing of long introns. Mol Cell 2023;83:2653\u20132672.","DOI":"10.1016\/j.molcel.2023.07.002"},{"key":"323_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01383-x","volume":"20","author":"X Wang","year":"2021","unstructured":"Wang X, Xing L, Yang R, Chen H, Wang M, Jiang R, et al. The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC. Mol Cancer. 2021;20:91.","journal-title":"Mol Cancer"},{"key":"323_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbrc.2019.03.005","volume":"512","author":"M Kang","year":"2019","unstructured":"Kang M, Lee SM, Kim W, Lee K-H, Kim D-Y. Fubp1 supports the lactate-Akt-mTOR axis through the upregulation of Hk1 and Hk2. Biochem Biophys Res Commun. 2019;512:93\u201399.","journal-title":"Biochem Biophys Res Commun"},{"key":"323_CR39","doi-asserted-by":"crossref","unstructured":"Frost JR, Mendez M, Soriano AM, Crisostomo L, Olanubi O, Radko S et al: Adenovirus 5 E1A-Mediated Suppression of p53 via FUBP1. J Virol 2018;92:e00439-18.","DOI":"10.1128\/JVI.00439-18"}],"container-title":["Nutrition & Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00323-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00323-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00323-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T17:08:38Z","timestamp":1722964118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-024-00323-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["323"],"URL":"https:\/\/doi.org\/10.1038\/s41387-024-00323-0","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,6]]},"assertion":[{"value":"6 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"(a) The study was approved by the Huaqiao University Animal Research Ethics Committee (Approval No. A2023047). All procedures involving animals were performed in compliance with the experimental animal guidelines of Huaqiao University. (b) This study involving human subjects, human material, or human data is all from the open public database. Ethical review and approval were waived, as all the data is freely available from public dataset, for example, GEO database, DAVID database, and STRING database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"60"}}